Cardiovascular Imaging Registry of Canada
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- University of Calgary
- Enrollment
- 45000
- Locations
- 4
- Primary Endpoint
- Malignant arrhythmic events
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.
Detailed Description
The Cardiovascular Imaging Registry of Canada (CIROC) was conceived to provide a common standardized architecture for the collection of clinically reported imaging biomarkers, demographic information, resource utilization and clinical outcomes among patients referred to non-invasive cardiac imaging. The Registry was designed to assess the feasibility of implementing personalized care strategies through automated high quality data collection and patient engagement. The CIROC Registry was launched with inaugural focus on Cardiac MRI base phenotyping, however has evolved to encompass cardiac CTA and echocardiography. Clinically referred patients are engaged by automated, tablet-based tools to collect informed consent and deploy standardized patient health assessments. Standardized reporting of disease features are captured using bespoke reporting tools. All patients are prospectively followed for a period of 10-years using linkage to administrative health data, inclusive of ICD-coded events, laboratory test results, ECG and vital statistics.
Investigators
James White
MD, FRCP(C) Director - Stephenson Cardiac Imaging Centre
University of Calgary
Eligibility Criteria
Inclusion Criteria
- •All patients referred for hospital-based cardiac imaging services
Exclusion Criteria
- •Failure or provide informed consent
Outcomes
Primary Outcomes
Malignant arrhythmic events
Time Frame: 2024
Composite of sudden cardiac death or appropriate ICD shock
Heart failure events
Time Frame: 2024
Composite of heart failure admission, death or need for transplantation / LVAD
Atrial arrhythmic events
Time Frame: 2024
Occurrence of atrial fibrillation / atrial flutter (documented by 12-lead ECG or Holter monitor)
Major adverse cardiovascular outcomes (MACE)
Time Frame: 2024
Composite of all-cause death, heart failure admission, myocardial infarction, heart transplantation or LVAD, Stroke or TIA
All-cause mortality
Time Frame: 2024
Death based on Vital Statistics Alberta and In-hospital coded death